IE
CAPR icon

Israel Englander’s Capricor Therapeutics CAPR Stock Holding History

Israel Englander’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.63M Sell
233,926
-122,428
-34% -$3.71M ﹤0.01% 2879
2026
Q1 		$10.8M Sell
356,354
-325,990
-48% -$8.69M ﹤0.01% 2096
2025
Q4 		$19.7M Buy
682,344
+479,885
+237% +$6.27M 0.01% 1594
2025
Q3 		$1.46M Buy
202,459
+28,611
+16% +$211K ﹤0.01% 4328
2025
Q2 		$1.73M Sell
173,848
-48,222
-22% -$509K ﹤0.01% 4009
2025
Q1 		$2.11M Buy
222,070
+106,428
+92% +$1.48M ﹤0.01% 3726
2024
Q4 		$1.6M Buy
115,642
+20,885
+22% +$366K ﹤0.01% 3815
2024
Q3 		$1.44M Sell
94,757
-384,753
-80% -$1.9M ﹤0.01% 3985
2024
Q2 		$2.29M Buy
479,510
+186,469
+64% +$1.04M ﹤0.01% 3428
2024
Q1 		$1.99M Buy
293,041
+272,003
+1,293% +$1.32M ﹤0.01% 3744
2023
Q4 		$103K Sell
21,038
-23,750
-53% -$77.3K ﹤0.01% 5342
2023
Q3 		$153K Buy
+44,788
New +$252K ﹤0.01% 5217
2023
Q1 		– Sell
-52,728
Closed -$204K – 6401
2022
Q4 		$204K Buy
52,728
+25,440
+93% +$121K ﹤0.01% 5324
2022
Q3 		$164K Buy
+27,288
New +$140K ﹤0.01% 5761
2021
Q3 		– Sell
-13,544
Closed -$69K – 6805
2021
Q2 		$69K Sell
13,544
-8,846
-40% -$37.5K ﹤0.01% 6323
2021
Q1 		$105K Sell
22,390
-26,967
-55% -$155K ﹤0.01% 5680
2020
Q4 		$169K Buy
+49,357
New +$214K ﹤0.01% 4904
2016
Q3 		– Sell
-1,857
Closed -$73K – 3280
2016
Q2 		$73K Hold
1,857
– – ﹤0.01% 3052
2016
Q1 		$47K Hold
1,857
– – ﹤0.01% 3154
2015
Q4 		$57K Hold
1,857
– – ﹤0.01% 3300
2015
Q3 		$75K Hold
1,857
– – ﹤0.01% 3306
2015
Q2 		$94K Hold
1,857
– – ﹤0.01% 3177
2015
Q1 		$160K Buy
+1,857
New +$160K ﹤0.01% 3339

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Israel Englander's CAPR Position: Q2 2026 in Review

Israel Englander reduced its Capricor Therapeutics (CAPR) stake by 34% in Q2 2026, selling an estimated $3.71M and leaving 233,926 shares worth $5.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2879.

Israel Englander first reported a position in CAPR in Q1 2015 and has held it in 23 quarters since. The position peaked at $19.7M in Q4 2025. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Israel Englander held 233,926 shares of Capricor Therapeutics worth $5.63M as of Q2 2026.
  • Israel Englander sold 122,428 Capricor Therapeutics shares in Q2 2026, an estimated $3.71M.
  • Capricor Therapeutics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2879 holding.
  • Israel Englander first reported a position in Capricor Therapeutics in Q1 2015 and has held it in 23 quarters since.
  • Israel Englander's Capricor Therapeutics position peaked at $19.7M in Q4 2025.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.